China Galectin 3 Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Galectin 3 market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Galectin 3 market. Detailed analysis of key players, along with key growth strategies adopted by Galectin 3 industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • MandalMed Inc

    • Bristol-Myers Squibb Company

    • Angion Biomedica Corp

    • Galectin Therapeutics Inc

    • GlycoMimetics Inc

    • iTeos Therapeutics SA

    By Type:

    • GAL-300

    • GRMD-03

    • ANG-4021

    • KTI

    • Others

    By End-User:

    • Liver Cirrhosis

    • Portal Hypertension

    • Metastatic Melanoma

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Galectin 3 Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Galectin 3 Market Size and Growth Rate of GAL-300 from 2016 to 2027

    • 1.3.2 China Galectin 3 Market Size and Growth Rate of GRMD-03 from 2016 to 2027

    • 1.3.3 China Galectin 3 Market Size and Growth Rate of ANG-4021 from 2016 to 2027

    • 1.3.4 China Galectin 3 Market Size and Growth Rate of KTI from 2016 to 2027

    • 1.3.5 China Galectin 3 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Galectin 3 Market Size and Growth Rate of Liver Cirrhosis from 2016 to 2027

    • 1.4.2 China Galectin 3 Market Size and Growth Rate of Portal Hypertension from 2016 to 2027

    • 1.4.3 China Galectin 3 Market Size and Growth Rate of Metastatic Melanoma from 2016 to 2027

    • 1.4.4 China Galectin 3 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Galectin 3 Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Galectin 3 by Major Types

    • 3.4.1 Market Size and Growth Rate of GAL-300

    • 3.4.2 Market Size and Growth Rate of GRMD-03

    • 3.4.3 Market Size and Growth Rate of ANG-4021

    • 3.4.4 Market Size and Growth Rate of KTI

    • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Galectin 3 Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Galectin 3 by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Galectin 3 in Liver Cirrhosis

    • 4.4.2 Market Size and Growth Rate of Galectin 3 in Portal Hypertension

    • 4.4.3 Market Size and Growth Rate of Galectin 3 in Metastatic Melanoma

    • 4.4.4 Market Size and Growth Rate of Galectin 3 in Others

    5 Market Analysis by Regions

    • 5.1 China Galectin 3 Production Analysis by Regions

    • 5.2 China Galectin 3 Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Galectin 3 Landscape Analysis

    • 6.1 North China Galectin 3 Landscape Analysis by Major Types

    • 6.2 North China Galectin 3 Landscape Analysis by Major End-Users

    7 Central China Galectin 3 Landscape Analysis

    • 7.1 Central China Galectin 3 Landscape Analysis by Major Types

    • 7.2 Central China Galectin 3 Landscape Analysis by Major End-Users

    8 South China Galectin 3 Landscape Analysis

    • 8.1 South China Galectin 3 Landscape Analysis by Major Types

    • 8.2 South China Galectin 3 Landscape Analysis by Major End-Users

    9 East China Galectin 3 Landscape Analysis

    • 9.1 East China Galectin 3 Landscape Analysis by Major Types

    • 9.2 East China Galectin 3 Landscape Analysis by Major End-Users

    10 Northeast China Galectin 3 Landscape Analysis

    • 10.1 Northeast China Galectin 3 Landscape Analysis by Major Types

    • 10.2 Northeast China Galectin 3 Landscape Analysis by Major End-Users

    11 Southwest China Galectin 3 Landscape Analysis

    • 11.1 Southwest China Galectin 3 Landscape Analysis by Major Types

    • 11.2 Southwest China Galectin 3 Landscape Analysis by Major End-Users

    12 Northwest China Galectin 3 Landscape Analysis

    • 12.1 Northwest China Galectin 3 Landscape Analysis by Major Types

    • 12.2 Northwest China Galectin 3 Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 MandalMed Inc

      • 13.1.1 MandalMed Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Bristol-Myers Squibb Company

      • 13.2.1 Bristol-Myers Squibb Company Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Angion Biomedica Corp

      • 13.3.1 Angion Biomedica Corp Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Galectin Therapeutics Inc

      • 13.4.1 Galectin Therapeutics Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 GlycoMimetics Inc

      • 13.5.1 GlycoMimetics Inc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 iTeos Therapeutics SA

      • 13.6.1 iTeos Therapeutics SA Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Galectin 3 Market Size and Growth Rate of GAL-300 from 2016 to 2027

    • Figure China Galectin 3 Market Size and Growth Rate of GRMD-03 from 2016 to 2027

    • Figure China Galectin 3 Market Size and Growth Rate of ANG-4021 from 2016 to 2027

    • Figure China Galectin 3 Market Size and Growth Rate of KTI from 2016 to 2027

    • Figure China Galectin 3 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Galectin 3 Market Size and Growth Rate of Liver Cirrhosis from 2016 to 2027

    • Figure China Galectin 3 Market Size and Growth Rate of Portal Hypertension from 2016 to 2027

    • Figure China Galectin 3 Market Size and Growth Rate of Metastatic Melanoma from 2016 to 2027

    • Figure China Galectin 3 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Galectin 3 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Galectin 3 Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Galectin 3

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Galectin 3 by Different Types from 2016 to 2027

    • Table Consumption Share of Galectin 3 by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of GAL-300

    • Figure Market Size and Growth Rate of GRMD-03

    • Figure Market Size and Growth Rate of ANG-4021

    • Figure Market Size and Growth Rate of KTI

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Galectin 3 by Different End-Users from 2016 to 2027

    • Table Consumption Share of Galectin 3 by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Liver Cirrhosis

    • Figure Market Size and Growth Rate of Portal Hypertension

    • Figure Market Size and Growth Rate of Metastatic Melanoma

    • Figure Market Size and Growth Rate of Others

    • Table China Galectin 3 Production by Regions

    • Table China Galectin 3 Production Share by Regions

    • Figure China Galectin 3 Production Share by Regions in 2016

    • Figure China Galectin 3 Production Share by Regions in 2021

    • Figure China Galectin 3 Production Share by Regions in 2027

    • Table China Galectin 3 Consumption by Regions

    • Table China Galectin 3 Consumption Share by Regions

    • Figure China Galectin 3 Consumption Share by Regions in 2016

    • Figure China Galectin 3 Consumption Share by Regions in 2021

    • Figure China Galectin 3 Consumption Share by Regions in 2027

    • Table North China Galectin 3 Consumption by Types from 2016 to 2027

    • Table North China Galectin 3 Consumption Share by Types from 2016 to 2027

    • Figure North China Galectin 3 Consumption Share by Types in 2016

    • Figure North China Galectin 3 Consumption Share by Types in 2021

    • Figure North China Galectin 3 Consumption Share by Types in 2027

    • Table North China Galectin 3 Consumption by End-Users from 2016 to 2027

    • Table North China Galectin 3 Consumption Share by End-Users from 2016 to 2027

    • Figure North China Galectin 3 Consumption Share by End-Users in 2016

    • Figure North China Galectin 3 Consumption Share by End-Users in 2021

    • Figure North China Galectin 3 Consumption Share by End-Users in 2027

    • Table Central China Galectin 3 Consumption by Types from 2016 to 2027

    • Table Central China Galectin 3 Consumption Share by Types from 2016 to 2027

    • Figure Central China Galectin 3 Consumption Share by Types in 2016

    • Figure Central China Galectin 3 Consumption Share by Types in 2021

    • Figure Central China Galectin 3 Consumption Share by Types in 2027

    • Table Central China Galectin 3 Consumption by End-Users from 2016 to 2027

    • Table Central China Galectin 3 Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Galectin 3 Consumption Share by End-Users in 2016

    • Figure Central China Galectin 3 Consumption Share by End-Users in 2021

    • Figure Central China Galectin 3 Consumption Share by End-Users in 2027

    • Table South China Galectin 3 Consumption by Types from 2016 to 2027

    • Table South China Galectin 3 Consumption Share by Types from 2016 to 2027

    • Figure South China Galectin 3 Consumption Share by Types in 2016

    • Figure South China Galectin 3 Consumption Share by Types in 2021

    • Figure South China Galectin 3 Consumption Share by Types in 2027

    • Table South China Galectin 3 Consumption by End-Users from 2016 to 2027

    • Table South China Galectin 3 Consumption Share by End-Users from 2016 to 2027

    • Figure South China Galectin 3 Consumption Share by End-Users in 2016

    • Figure South China Galectin 3 Consumption Share by End-Users in 2021

    • Figure South China Galectin 3 Consumption Share by End-Users in 2027

    • Table East China Galectin 3 Consumption by Types from 2016 to 2027

    • Table East China Galectin 3 Consumption Share by Types from 2016 to 2027

    • Figure East China Galectin 3 Consumption Share by Types in 2016

    • Figure East China Galectin 3 Consumption Share by Types in 2021

    • Figure East China Galectin 3 Consumption Share by Types in 2027

    • Table East China Galectin 3 Consumption by End-Users from 2016 to 2027

    • Table East China Galectin 3 Consumption Share by End-Users from 2016 to 2027

    • Figure East China Galectin 3 Consumption Share by End-Users in 2016

    • Figure East China Galectin 3 Consumption Share by End-Users in 2021

    • Figure East China Galectin 3 Consumption Share by End-Users in 2027

    • Table Northeast China Galectin 3 Consumption by Types from 2016 to 2027

    • Table Northeast China Galectin 3 Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Galectin 3 Consumption Share by Types in 2016

    • Figure Northeast China Galectin 3 Consumption Share by Types in 2021

    • Figure Northeast China Galectin 3 Consumption Share by Types in 2027

    • Table Northeast China Galectin 3 Consumption by End-Users from 2016 to 2027

    • Table Northeast China Galectin 3 Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Galectin 3 Consumption Share by End-Users in 2016

    • Figure Northeast China Galectin 3 Consumption Share by End-Users in 2021

    • Figure Northeast China Galectin 3 Consumption Share by End-Users in 2027

    • Table Southwest China Galectin 3 Consumption by Types from 2016 to 2027

    • Table Southwest China Galectin 3 Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Galectin 3 Consumption Share by Types in 2016

    • Figure Southwest China Galectin 3 Consumption Share by Types in 2021

    • Figure Southwest China Galectin 3 Consumption Share by Types in 2027

    • Table Southwest China Galectin 3 Consumption by End-Users from 2016 to 2027

    • Table Southwest China Galectin 3 Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Galectin 3 Consumption Share by End-Users in 2016

    • Figure Southwest China Galectin 3 Consumption Share by End-Users in 2021

    • Figure Southwest China Galectin 3 Consumption Share by End-Users in 2027

    • Table Northwest China Galectin 3 Consumption by Types from 2016 to 2027

    • Table Northwest China Galectin 3 Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Galectin 3 Consumption Share by Types in 2016

    • Figure Northwest China Galectin 3 Consumption Share by Types in 2021

    • Figure Northwest China Galectin 3 Consumption Share by Types in 2027

    • Table Northwest China Galectin 3 Consumption by End-Users from 2016 to 2027

    • Table Northwest China Galectin 3 Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Galectin 3 Consumption Share by End-Users in 2016

    • Figure Northwest China Galectin 3 Consumption Share by End-Users in 2021

    • Figure Northwest China Galectin 3 Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of MandalMed Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MandalMed Inc

    • Figure Sales and Growth Rate Analysis of MandalMed Inc

    • Figure Revenue and Market Share Analysis of MandalMed Inc

    • Table Product and Service Introduction of MandalMed Inc

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

    • Table Company Profile and Development Status of Angion Biomedica Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Angion Biomedica Corp

    • Figure Sales and Growth Rate Analysis of Angion Biomedica Corp

    • Figure Revenue and Market Share Analysis of Angion Biomedica Corp

    • Table Product and Service Introduction of Angion Biomedica Corp

    • Table Company Profile and Development Status of Galectin Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galectin Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Galectin Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Galectin Therapeutics Inc

    • Table Product and Service Introduction of Galectin Therapeutics Inc

    • Table Company Profile and Development Status of GlycoMimetics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlycoMimetics Inc

    • Figure Sales and Growth Rate Analysis of GlycoMimetics Inc

    • Figure Revenue and Market Share Analysis of GlycoMimetics Inc

    • Table Product and Service Introduction of GlycoMimetics Inc

    • Table Company Profile and Development Status of iTeos Therapeutics SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of iTeos Therapeutics SA

    • Figure Sales and Growth Rate Analysis of iTeos Therapeutics SA

    • Figure Revenue and Market Share Analysis of iTeos Therapeutics SA

    • Table Product and Service Introduction of iTeos Therapeutics SA


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.